Literature DB >> 27194770

Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.

Anjali Verma1, Pavithra Rajagopalan1, Rishikesh Lotke1, Rebu Varghese1, Deepak Selvam1, Tapas K Kundu2, Udaykumar Ranga3.   

Abstract

UNLABELLED: Of the various genetic subtypes of human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV), only in subtype C of HIV-1 is a genetically variant NF-κB binding site found at the core of the viral promoter in association with a subtype-specific Sp1III motif. How the subtype-associated variations in the core transcription factor binding sites (TFBS) influence gene expression from the viral promoter has not been examined previously. Using panels of infectious viral molecular clones, we demonstrate that subtype-specific NF-κB and Sp1III motifs have evolved for optimal gene expression, and neither of the motifs can be replaced by a corresponding TFBS variant. The variant NF-κB motif binds NF-κB with an affinity 2-fold higher than that of the generic NF-κB site. Importantly, in the context of an infectious virus, the subtype-specific Sp1III motif demonstrates a profound loss of function in association with the generic NF-κB motif. An additional substitution of the Sp1III motif fully restores viral replication, suggesting that the subtype C-specific Sp1III has evolved to function with the variant, but not generic, NF-κB motif. A change of only two base pairs in the central NF-κB motif completely suppresses viral transcription from the provirus and converts the promoter into heterochromatin refractory to tumor necrosis factor alpha (TNF-α) induction. The present work represents the first demonstration of functional incompatibility between an otherwise functional NF-κB motif and a unique Sp1 site in the context of an HIV-1 promoter. Our work provides important leads as to the evolution of the HIV-1 subtype C viral promoter with relevance for gene expression regulation and viral latency. IMPORTANCE: Subtype-specific genetic variations provide a powerful tool to examine how these variations offer a replication advantage to specific viral subtypes, if any. Only in subtype C of HIV-1 are two genetically distinct transcription factor binding sites positioned at the most critical location of the viral promoter. Since a single promoter regulates viral gene expression, the promoter variations can play a critical role in determining the replication fitness of the viral strains. Our work for the first time provides a scientific explanation for the presence of a unique NF-κB binding motif in subtype C, a major HIV-1 genetic family responsible for half of the global HIV-1 infections. The results offer compelling evidence that the subtype C viral promoter not only is stronger but also is endowed with a qualitative gain-of-function advantage. The genetically variant NF-κB and the Sp1III motifs may be respond differently to specific cell signal pathways, and these mechanisms must be examined.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27194770      PMCID: PMC4984642          DOI: 10.1128/JVI.00308-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Partners in transcription: NFAT and AP-1.

Authors:  F Macián; C López-Rodríguez; A Rao
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

2.  Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.

Authors:  Philippe Roof; Maria Ricci; Pierre Genin; Monty A Montano; Max Essex; Mark A Wainberg; Anne Gatignol; John Hiscott
Journal:  Virology       Date:  2002-04-25       Impact factor: 3.616

3.  Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India.

Authors:  Nagadenahalli Byrareddy Siddappa; Prashanta Kumar Dash; Anita Mahadevan; Anita Desai; Narayana Jayasuryan; Vasanthapuram Ravi; Parthasarathy Satishchandra; Susarla K Shankar; Udaykumar Ranga
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

4.  The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.

Authors:  D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

Review 5.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

6.  An infectious DNA clone of HIV type 1 subtype C.

Authors:  N Mochizuki; N Otsuka; K Matsuo; T Shiino; A Kojima; T Kurata; K Sakai; N Yamamoto; S Isomura; T N Dhole; Y Takebe; M Matsuda; M Tatsumi
Journal:  AIDS Res Hum Retroviruses       Date:  1999-09-20       Impact factor: 2.205

7.  Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells.

Authors:  Mingce Zhang; Adrian Clausell; Tanya Robinson; Jiyi Yin; Eric Chen; Leanne Johnson; Greta Weiss; Steffanie Sabbaj; Robert M Lowe; Fred H Wagner; Paul A Goepfert; Olaf Kutsch; Randy Q Cron
Journal:  J Immunol       Date:  2012-08-08       Impact factor: 5.422

8.  The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.

Authors:  Tim van Opijnen; Joost Kamoschinski; Rienk E Jeeninga; Ben Berkhout
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Reciprocal regulation of the nuclear factor of activated T cells and HIV-1.

Authors:  F Pessler; R Q Cron
Journal:  Genes Immun       Date:  2004-05       Impact factor: 2.676

10.  Control of stochastic gene expression by host factors at the HIV promoter.

Authors:  John C Burnett; Kathryn Miller-Jensen; Priya S Shah; Adam P Arkin; David V Schaffer
Journal:  PLoS Pathog       Date:  2009-01-09       Impact factor: 6.823

View more
  7 in total

1.  A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.

Authors:  Sutanuka Chakraborty; Manisha Kabi; Udaykumar Ranga
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

2.  NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.

Authors:  Hong Wang; Yue Liu; Chen Huan; Jing Yang; Zhaolong Li; Baisong Zheng; Yingchao Wang; Wenyan Zhang
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

4.  NF-κB Duplications in the Promoter-Variant HIV-1C LTR Impact Inflammation Without Altering Viral Replication in the Context of Simian Human Immunodeficiency Viruses and Opioid-Exposure.

Authors:  Rajnish S Dave; Haider Ali; Susmita Sil; Lindsey A Knight; Kabita Pandey; Lepakshe S V Madduri; Fang Qiu; Udaykumar Ranga; Shilpa Buch; Siddappa N Byrareddy
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

5.  An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.

Authors:  Haider Ali; Disha Bhange; Kavita Mehta; Yuvrajsinh Gohil; Harshit Kumar Prajapati; Siddappa N Byrareddy; Shilpa Buch; Udaykumar Ranga
Journal:  Retrovirology       Date:  2021-09-19       Impact factor: 4.602

Review 6.  HIV-1 Latency and Latency Reversal: Does Subtype Matter?

Authors:  Indra Sarabia; Alberto Bosque
Journal:  Viruses       Date:  2019-11-28       Impact factor: 5.048

7.  The Signature Amino Acid Residue Serine 31 of HIV-1C Tat Potentiates an Activated Phenotype in Endothelial Cells.

Authors:  Malini Menon; Roli Budhwar; Rohit Nandan Shukla; Kiran Bankar; Madavan Vasudevan; Udaykumar Ranga
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.